Skip to main content
SR biotek Inc. logo

SR biotek Inc. — Investor Relations & Filings

Ticker · 270210 ISIN · KR7270210008 KO Manufacturing
Open in API
Filings indexed 190 across all filing types
Latest filing 2022-03-02 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 270210

About SR biotek Inc.

http://srbiotek.com/

SR biotek Inc. is a biotechnology and cosmeceutical company specializing in the research, development, and manufacturing of innovative skincare products. The company offers comprehensive turnkey OEM/ODM solutions to its partners, covering product development, quality control, and manufacturing. A core strength lies in the development of novel ingredients, highlighted by its proprietary bio-material, RAPHITOX, which utilizes a micro-needle shaped structure. In addition to its manufacturing services, SR biotek also develops its own branded skincare lines.

Recent filings

Filing Released Lang Actions
유상증자또는주식관련사채등의청약결과(자율공시)(주주배정 유상증자)
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement regarding the results of a rights offering (paid-in capital increase) for SR Biotech. It details the number of shares subscribed, the subscription rate, and the treatment of unsubscribed shares. This falls under the category of share issuance and capital changes.
2022-03-02 Korean
소액공모공시서류(지분증권)
Capital/Financing Update Classification · 98% confidence The document is a 'Small-Scale Public Offering Disclosure Document' (소액공모공시서류) filed by SR Biotech. It details a capital increase (rights offering) of 333,333 shares, including the purpose of funds, subscription dates, and investment risk factors. This type of filing is a regulatory requirement for companies raising capital under a certain threshold without a full securities registration statement. In the context of the provided categories, this is a regulatory filing related to capital raising, which fits best under 'Regulatory Filings' (RNS) as it is a specific Korean regulatory disclosure document.
2022-01-20 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from a South Korean company, SR Biotech, specifically regarding a 'Capital Increase Decision' (유상증자결정). It details the issuance of new shares, pricing, and underwriting information. This falls under the category of share issuance and capital changes.
2022-01-20 Korean
권리락(유상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a short announcement regarding a 'rights offering' (유상증자) and the resulting 'ex-rights' (권리락) date for SR Biotech. It is a brief notification of a capital change event rather than a full report, fitting the criteria for a share-related capital change announcement.
2022-01-20 Korean
주주명부폐쇄기간또는기준일설정
Share Issue/Capital Change Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for shareholder register closure to facilitate a capital increase (rights offering). It does not contain the full financial report or the actual proxy materials, but rather serves as a formal notice of a corporate action. Given the nature of the announcement regarding share-related corporate actions and the lack of a specific category for 'Record Date' or 'Corporate Action Notice', it falls under the general regulatory filing category.
2022-01-10 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean financial authorities regarding a decision for a paid-in capital increase (유상증자결정). This type of filing specifically details the issuance of new shares, pricing, and allocation methods, which falls under the category of share issuance and capital changes.
2022-01-07 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.